KIMBERLY JAY: Open Payments
NPI 1174118020 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$319 in 10 payments from 6 companies in 2025. Trend: 2023 $523 · 2024 $543 · 2025 $319
Food & beverage: $319
| Company | Payments | Amount |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | 1 | $111 |
| ABBVIE INC. | 4 | $104 |
| GENZYME CORPORATION | 2 | $51 |
| Madrigal Pharmaceuticals | 1 | $22 |
| Intra-Sana Laboratories | 1 | $16 |
| Novo Nordisk Inc | 1 | $16 |
Products named: VOQUEZNA, LINZESS, DUPIXENT, REZDIFFRA, CREON, RELTONE 200 MG, Wegovy.
Industry payments across TX — which companies pay providers there.
